Published On Nov 24, 2021
Gibraltar
Population, 33,691
Has administered at least 94,469 vaccine doses
Enough to have fully vaccinated 140.2% of the country’s population.
Face masks required in all shops and supermarkets, public transport, in medical centres, indoor funerals, Airport.
https://www.worldometers.info/coronav...
Europe
https://www.who.int/emergencies/disea...
World Health Organization
Europe remains “in the firm grip”
Death toll could top 2.2 million this winter
Another 700,000 deaths by March 1
high or extreme stress in intensive care units (ICUs) in 49 out of 53 countries between now and March 1, 2022
Director for WHO Europe, Hans Kluge
face a challenging winter ahead
vaccine plus
Face masks reduce COVID incidence
by 53 %
Over 160,000 deaths could be prevented (by March 1) if universal mask coverage of 95%
Pascal Soriot, the chief executive of AstraZeneca
https://www.telegraph.co.uk/news/2021...
UK not seeing so many hospitalisations relative to Europe despite a high number of cases.
Long term T cell immunity after antibodies wane
Looks like, AstraZeneca initially gives higher levels of T-cells
France, Germany, Spain, Belgium – restricted AZ to the under 65s
UK may have high T cells from natural infection and cross immunity from other coronavirus infections
Government source
European leaders had all these unfounded concerns about AstraZeneca and its use in older people
If you look at the data, you can see us using it early has been incredibly helpful in terms of protecting older and vulnerable people from this disease for longer
Dr Peter English
People whose immune systems have produced a strong T-cell response but a weaker antibody response might be more likely to be infected in the first place
but more likely to be able to fight the infection, and they will be much less likely to develop severe disease
It is plausible that this generated an excellent T-cell response, which means that while people can still be infected and infectious, they are unlikely to be seriously unwell
Prof Matthew Snape, Oxford University
The best T-cell responses seem to come if you give a first dose of the AstraZeneca vaccine followed by Pfizer
Prof Dame Sarah Gilbert
Third jabs may be unnecessary
UK
https://coronavirus.data.gov.uk
US
https://www.cdc.gov/coronavirus/2019-...
Centers for Disease Control and Prevention Director Rochelle Walensky
Seven-day average
Cases up 18%
Hospital admissions up 6%
135 million people eligible for boosters
Heading into the winter months, when respiratory viruses are more likely to spread,
and with plans for increased holiday season travel and gatherings,
boosting people’s overall protection against covid-19 disease and death was important to do now
In the fully vaccinated
https://www.cdc.gov/coronavirus/2019-...
Infections happen in only a small proportion of people who are fully vaccinated, even with the Delta variant.
When these infections occur among vaccinated people, they tend to be mild
If you are fully vaccinated and become infected with the Delta variant, you can spread the virus to others
Dr Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases
https://www.businessinsider.com/fauci...
Next spring
Pfizer trial ongoing
6 months to 5 years
Moderna and Johnson & Johnson, have pediatric vaccine trials planned
Emergency use authorization to the Food and Drug Administration
Canada
https://www.canada.ca/en/health-canad...
Health Canada
Pfizer-BioNTech Comirnaty, in children 5 to 11 years
(12 to 15s, May 5, 2021)
the Department has determined that the benefits of this vaccine for children between 5 and 11 years of age outweigh the risks
Two-dose regimen, 10 micrograms
Three weeks apart
Immune response in children 5 to 11 years, comparable to 16 to 25
The vaccine was 90.7% effective at preventing COVID-19 in children 5 to 11 years of age
and no serious side effects were identified
Ongoing studies and real-world data
to ensure that the benefits of the vaccine continue to outweigh any risks, as well as to detect any potential new safety signals in any age group
